Inventor · disambiguated record
Guozhi Tang
Also filed as: TANG GUOZHI
15 granted patents·12 pending applications·68 citations·filing 2005–2023
89Inventor score
Files withHOFFMANN LA ROCHE11ASCENTAGE PHARMA SUZHOU CO LTD6SHANGHAI VISONPHARMA CO LTD4CHEN LI1GUO LEI1
Top patents by PatentIndex Score
27 records- 0194US10669268B2Bicyclic derivativesHOFFMANN LA ROCHE·Filed 2017·Granted Jun 2, 2020·9 cites·55 claims
- 0294US9447086B26-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2013·Granted Sep 20, 2016·34 cites·5 claims
- 0389US11312724B2Spirocyclic tetrahydroquinazolinesASCENTAGE PHARMA SUZHOU CO LTD·Filed 2021·Granted Apr 26, 2022·4 cites·14 claims
- 0487US8557812B2Small molecule inhibitors of anti-apoptotic BCL-2 family members and the uses thereofWANG SHAOMENG·Filed 2005·Granted Oct 15, 2013·9 cites·7 claims
- 0582US10913745B2Octahydro-pyrrolo[3,4-c]-pyrrole derivatives and analogs thereof as autotaxin inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Feb 9, 2021·3 cites·39 claims
- 0679US11691989B2Macrocyclic indoles as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2019·Granted Jul 4, 2023·3 cites·41 claims
- 0778US8716285B2N-hydroxy-benzamids for the treatment of cancerGUO LEI·Filed 2011·Granted May 6, 2014·5 cites·32 claims
- 0868US2020339570A1Bicyclic derivativesHOFFMANN LA ROCHE·Filed 2020·Application pending·0 cites
- 0960US2025195524A1Pyrimido-pyridazinone compound as toll-like receptor agonistSHANGHAI VISONPHARMA CO LTD·Filed 2023·Application pending·0 cites
- 1060US2017050960A1New bicyclic derivativesHOFFMANN LA ROCHE·Filed 2016·Application pending·0 cites
- 1159US2025059183A1Pyridine[4,3-d]pyrimidine compound as tlr7/8 agonistSHANGHAI VISONPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1258US8404738B24-amino-N-hydroxy-benzamides for the treatment of cancerLIN XIANFENG·Filed 2012·Granted Mar 26, 2013·1 cites·21 claims
- 1357US2015353559A1New bicyclic derivativesHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 1454US2024124486A1Macrocyclic tlr7 agonist, preparation method therefor, pharmaceutical composition and use thereofSHANGHAI VISONPHARMA CO LTD·Filed 2021·Application pending·0 cites
- 1554US2024166649A1Dihydropyrimidine compound, preparation method therefor and application thereofSHANGHAI VISONPHARMA CO LTD·Filed 2022·Application pending·0 cites
- 1653US2013267517A1Novel 4-methyl-dihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infectionHOFFMANN LA ROCHE·Filed 2013·Application pending·0 cites
- 1752US8202866B2Ortho-aminoanilides for the treatment of cancerLIANG CHUNGEN·Filed 2009·Granted Jun 19, 2012·0 cites·6 claims
- 1851US9856247B24-methyl-dihydropyrimidines for the treatment and prophylaxis of Hepatitis B virus infectionHOFFMANN LA ROCHE·Filed 2015·Granted Jan 2, 2018·0 cites·18 claims
- 1950US2015376194A1NEW OCTAHYDRO-PYRROLO[3,4-c]-PYRROLE DERIVATIVES AND ANALOGS THEREOF AS AUTOTAXIN INHIBITORSHOFFMANN LA ROCHE·Filed 2015·Application pending·0 cites
- 2048US11987575B2Tricyclic compounds as BCR-ABL inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted May 21, 2024·0 cites·30 claims
- 2145US12319703B2Macrocyclic fused pyrazoles as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Jun 3, 2025·0 cites·20 claims
- 2245US2022332701A1Heterocyclic compounds as bcr-abl inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Application pending·0 cites
- 2344US10597380B2Pyridazinone-based broad spectrum anti-influenza inhibitorsHOFFMANN LA ROCHE·Filed 2018·Granted Mar 24, 2020·0 cites·42 claims
- 2443US11498928B2Macrocyclic spiroethers as Mcl-1 inhibitorsASCENTAGE PHARMA SUZHOU CO LTD·Filed 2020·Granted Nov 15, 2022·0 cites·47 claims
- 2543US2006247305A1Chromen-4-one inhibitors of anti-apoptotic Bcl-2 family members and the uses thereofUNIV MICHIGAN·Filed 2006·Application pending·0 cites
- 2636US7977372B2Ortho aminoamides for the treatment of cancerHOFFMANN LA ROCHE·Filed 2010·Granted Jul 12, 2011·0 cites·12 claims
- 2736US2011195979A1Compounds for the treatment and prevention of influenzaCHEN LI·Filed 2011·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →